Categories
Uncategorized

Retrophin, Founded by Martin Shkreli, Rebrands Itself as Travere Therapeutics

Retrophin Inc., a biopharmaceutical company founded by now-convicted drug executive Martin Shkreli, is rebranding itself as Travere Therapeutics Inc.
The new name—which company officials say is a nod to the Latin roots for truth and path—severs another tie to its founder, Mr. Shkreli, who is serving prison time for securities fraud related to his management of two hedge funds and Retrophin. He is scheduled to be released in 2023.
Mr….
WSJ Membership
Customer Service
Tools & Features
Ads
More
Dow Jones Products

source

Leave a Reply

Your email address will not be published. Required fields are marked *